Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36.
暂无分享,去创建一个
S. Horiuchi | R. Nagai | Y. Unno | H. Nakayama | A. Kuniyasu | M. Sakai | Y. Sakamoto
[1] K. Ohba,et al. Cellular Carbonyl Stress Enhances the Expression of Plasminogen Activator Inhibitor-1 in Rat White Adipocytes via Reactive Oxygen Species-dependent Pathway* , 2004, Journal of Biological Chemistry.
[2] S. Kihara,et al. Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[3] S. Davis,et al. Leptin: metabolic control and regulation. , 2003, Journal of diabetes and its complications.
[4] S. Horiuchi,et al. CD36‐mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3‐L1 and human subcutaneous adipocytes , 2003, FEBS letters.
[5] S. Horiuchi,et al. Identification in Human Atherosclerotic Lesions of GA-pyridine, a Novel Structure Derived from Glycolaldehyde-modified Proteins* , 2002, The Journal of Biological Chemistry.
[6] M. Tsujimoto,et al. FEEL-1, a Novel Scavenger Receptor with in Vitro Bacteria-binding and Angiogenesis-modulating Activities* , 2002, The Journal of Biological Chemistry.
[7] H. Nakayama,et al. Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. , 2002, Biochemical and biophysical research communications.
[8] T. Matsuo,et al. Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.
[9] Hiroyuki Arai,et al. CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products* , 2001, The Journal of Biological Chemistry.
[10] K. Matsumoto,et al. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. , 2000, Diabetes.
[11] R. Bucala,et al. Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo , 2000, Molecular medicine.
[12] M. Hori,et al. Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. , 2000, American journal of physiology. Heart and circulatory physiology.
[13] Satoshi Tanaka,et al. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .
[14] G. Inoue,et al. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. , 1999, Diabetes.
[15] R. Silverstein,et al. A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.
[16] G. Boden,et al. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene. , 1999, Metabolism: clinical and experimental.
[17] T. Kodama,et al. Induction of Murine Macrophage Growth by Oxidized Low Density Lipoprotein Is Mediated by Granulocyte Macrophage Colony-stimulating Factor* , 1998, The Journal of Biological Chemistry.
[18] V. Emilsson,et al. Leptin Action in Intestinal Cells* , 1998, The Journal of Biological Chemistry.
[19] T. Miyata,et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. , 1998, Journal of the American Society of Nephrology : JASN.
[20] T. Kita,et al. An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.
[21] M. Lazar,et al. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Stocker,et al. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. , 1996, The Journal of clinical investigation.
[23] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[24] S. Yamashita,et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.
[25] Yong Ming Li,et al. Identification of Galectin-3 As a High-Affinity Binding Protein for Advanced Glycation End Products (AGE): A New Member of the AGE-Receptor Complex , 1995, Molecular medicine.
[26] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[27] V. Monnier,et al. Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction (*) , 1995, The Journal of Biological Chemistry.
[28] R. Silverstein,et al. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[29] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[30] A. Daugherty,et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.
[31] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[32] K. O. Elliston,et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.
[33] M. Freeman,et al. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.
[34] A. Mcfarlane,et al. Efficient Trace-labelling of Proteins with Iodine , 1958, Nature.